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Abstract. 
 
Previous data have shown that reducing 
agents disrupt the structure of vaccinia virus (vv). Here, 
we have analyzed the disulfide bonding of vv proteins 
in detail. In vv-infected cells cytoplasmically synthe-
sized vv core proteins became disulfide bonded in the 
newly assembled intracellular mature viruses (IMVs). 
vv membrane proteins also assembled disulfide bonds, 
but independent of IMV formation and to a large ex-
tent on their cytoplasmic domains. If disulfide bonding 
was prevented, virus assembly was only partially im-
paired as shown by electron microscopy as well as a 
biochemical assay of IMV formation. Under these con-
ditions, however, the membranes around the isolated 
particles appeared less stable and detached from the 
underlying core. During the viral infection process
the membrane proteins remained disulfide bonded, 
whereas the core proteins were reduced, concomitant 
with delivery of the cores into the cytoplasm. Our data 
show that vv has evolved an unique system for the as-
sembly of cytoplasmic disulfide bonds that are localized 
both on the exterior and interior parts of the IMV.
Key words: poxviridae ¥ viral assembly ¥ vaccinia vi-
rus ¥ disulfide bonding ¥ reducing agents
 
T
 
HE
 
 formation of disulfide bonds during (re)folding
of proteins in vitro has been well documented (re-
viewed in 15). Most of the recent interest in protein
folding, however, has concentrated on the folding and dis-
ulfide bond formation in (mammalian) cells. It is now well
accepted that disulfide bonding and folding of proteins oc-
cur in the lumen of the ER. The unique (GSH/GSSG)
 
1
 
 ra-
 
tio (of 
 
z
 
3:1) within the lumen of this compartment is
thought to provide it with a redox potential that, in con-
trast to the cytosol (ratio 100:1), is oxidizing enough to fa-
vor disulfide bonding (24). Moreover, the ER lumen con-
tains a variety of molecular chaperones that assist in the
folding reactions (for review see 17, 19, 20). Finally, this
compartment is equipped with an abundant nonmem-
brane protein, protein disulfide isomerase (PDI), that
from in vitro experiments (3, 5), as well as from genetic ev-
idence (36), plays an important role in the disulfide bond-
ing of proteins in the ER. PDI contains two, thioredoxin-
 
like motifs, a sequence of 11 amino acids that aligns with
a corresponding sequence in the 
 
Escherichia coli
 
 thiore-
doxin protein (reviewed in 15, 16). This latter protein may
be involved in catalyzing reduction (21). Other proteins
that contain thioredoxin motifs include glutaredoxin (21),
 
E. coli
 
 DsbA (the 
 
E. coli
 
 equivalent of PDI), and the ER
proteins ERp72 and ERp60. These proteins contain the
characteristic active site sequence composed of CXXC in
which the cysteine residues act as redox-active groups
(16).
Viral membrane proteins have been used extensively to
study the disulfide bonding and folding processes in the
ER lumen (reviewed in 10). They appear to follow the
same rules as cellular proteins in that they are inserted in a
cotranslational manner into the ER where they undergo
folding and oligomerization reactions. Moreover, they
provide an advantage over cellular proteins in being abun-
 
dantly expressed upon viral infection, thus facilitating
detailed studies of these processes. Recent results using
the well-characterized influenza virus hemagglutinin (HA)
protein, have shown that upon addition of DTT to living
cells, newly synthesized HA remains reduced in the lumen
of the ER while already synthesized and disulfide bonded
molecules become reduced as long as they resided inside
the ER (2). This observation has subsequently been tested
with other proteins, mostly with similar results (for exam-
ple see 37, 45, 56).
Disulfide bonding can occur within one molecule (in-
tramolecular) where two cysteines are bridged by a disul-
fide bond allowing the molecule to fold. Other types of
disulfide bonds may be intermolecular, whose role can be
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to link different subunits of a complex or to assemble sub-
units of one protein into a higher homo-oligomeric form.
An example of this latter process is the posttranslational
dimerization of the equine arteritis virus G
 
s
 
 membrane
protein (9). The general consensus is that this kind of dis-
ulfide bonding also occurs in the lumen of the ER.
Vaccinia virus (vv), the best studied member of the pox-
viridae, is the largest and most complex of animal viruses
known, measuring 
 
z
 
350 nm in its largest dimension. It
contains a dsDNA genome of 
 
z
 
190 kB encoding for 
 
.
 
200
proteins, of which 
 
z
 
100 seem to be associated with the
virion (14). vv is unique in that during its life cycle two in-
fectious forms are made, the intracellular mature virus
(IMV) and the extracellular enveloped virus (EEV; 40).
We have recently shown that the IMV membranes are de-
rived from the intermediate compartment (IC) located be-
tween the ER and the Golgi complex (53), a finding that is
consistent with the fact that at least three of its membrane
proteins insert cotranslationally into the RER and are re-
tained in the IC in infected cells (34, 51). Although the
detailed structure of the IMV is unknown, it is generally
accepted that the virion is composed of a membrane-
enclosed, brick-shaped core that contains four particularly
abundant proteins, 4a (gene A10L), 4b (A3L), and the
11-kD (F17R) and 25-kD (L4R) putative DNA-binding
proteins (see Fig. 1 and Table I). The surface of the viral
core is studded with a spike-like structure, that comprises,
at least in part, an abundant 39-kD protein (A4L; 8, 50).
The IC-derived cisternal membranes that surround the
core contain three highly abundant membrane proteins of
16 (A14L), 21 (A17L), and 8 (A13L) kD (26, 51), as well
as a peripheral membrane protein p14 (A27L; 47, 49, 54).
Furthermore the IMV membrane contains a set of less
abundant membrane proteins such as p32 (D8L; 43), p35
(H3L; 4), and a 27-kD myristoylated protein (L1R; 60; see
Fig. 1 and Table I).
The IMV structure is highly dependent on disulfide
bonds. It is well known that the removal of the viral mem-
branes from the underlying core structure requires a mix-
ture of a nonionic detergent and a reducing agent such as
 
b
 
-mercaptoethanol (12, 22, 52). More recent evidence for
the sensitivity of the viral structure to reducing agents
comes from the work of Roos et al. (50) showing that
treatment of intact IMV with DTT induces the enveloping
cisternal membranes to peel off the underlying core, as as-
sessed by a novel cryo-EM technique. At the biochemical
level several studies have indeed shown that vv membrane
proteins may be disulfide bonded. Thus, the two abundant
membrane proteins p21 and p16 as well as p32 have been
shown to form disulfide bonded dimers (38, 47, 49). Since
these latter proteins are associated with the IMV mem-
brane, their disulfide bonding could logically be expected
to occur in the lumen of the ER, following the accepted
rules of disulfide bonding in vivo (see above). However,
our recent detailed characterization of the topology of
some of those proteins appeared to show that the cysteines
potentially involved in disulfide bonding may be located in
the cytoplasm (for example see 34, 51). Several studies
have also suggested that cytoplasmically synthesized vv
core proteins may form disulfide bonds. The work by Oie
and Ichihashi (44) and Ichihashi et al. (25) described disul-
fide bonding of several proteins that were not further
 
identified, but that from their characteristic migration in
SDS-PAGE could be expected to be viral core proteins.
These combined data seemed at odds with the current
dogma on the intracellular formation of disulfide bonds.
Until now we had rationalized by assuming that such cyto-
plasmic disulfide bonds were the result of after lysis oxida-
tion, since in most of the relevant studies no alkylating
reagent was used to prevent such (artifactual) disulfide
bonding.
In this paper, we have investigated the vv disulfide
bonds in more detail. Under conditions in which artifac-
tual disulfide bonding is prevented, we show that the three
vv core proteins that were analyzed are disulfide bonded
in the IMV (and EEV) but not when IMV assembly is pre-
vented. We also show that three vv membrane proteins
form disulfide bonded dimers and, unexpectedly, in some
cases on their cytoplasmic domains. We present data to
show that these disulfide bonds seem required to assemble
the membranes tightly around the core. When vv infects a
new cell, these disulfide bonds are reduced on the core
proteins whereas those on the membrane proteins remain
disulfide bonded.
 
Materials and Methods
 
Cells, Viruses, Antibodies, and Plasmids
 
HeLa and BSC40 cells were grown as previously described (53). The WR
strain of vaccinia virus was propagated as described (11). The vv recombi-
nant expressing the MHV-M protein, as well as the COOH and NH
 
2
 
 ter-
minus-specific antibodies to the M protein were described before (51).
The following antibodies were used throughout this study; a peptide anti-
body to p16 (A14L; 51), to p11(F17R; 26), antibodies to p25 (L4R), and 4a
(A10L) were a kind gift of Dr. Hruby (Oregon State University, Corvalis,
OR; 57, 58); the antibodies to p39 (A4L) were a gift of Dr. Esteban (Na-
tional Centre of Biotechnology, Madrid, Spain; 39); and the antibodies to
p32 (D8L) were a gift of Dr. Niles (SUNY Medical School, Buffalo, NY;
43). To make antibodies to p21 (A17L) and p35 (H3L) peptides matching
amino acid 17 through 37 of p21 and amino acid 31 through 43 of the H3L
sequence were synthesized. Antibodies were made according to Cudmore
et al. (8). One OD
 
260
 
 unit of purified WR was treated with NP-40 and
DTT to make viral cores as described by Cudmore et al. (8). The cores
were fixed for 30 min at room temperature with 0.5% glutaraldehyde in 10
mM Tris-Cl, pH 9, and an antibody, further referred to as anti-core anti-
body was generated as described by Cudmore et al. (8).
Preparation of post-nuclear supernatants (PNS) of infected cells and of
NEM-treated WR and detection of vv proteins by Western blots.
For the preparation of PNS of infected cells, Hela cells grown in 10-cm
dishes were infected with a MOI of 10 for 60 min at 37
 
8
 
C and then incu-
bated overnight in the presence or absence of 100 
 
m
 
g/ml rifampicin
(Sigma; from a 100 mg/ml stock in DMSO kept at 
 
2
 
20
 
8
 
C). The cells were
put on ice, washed twice with ice-cold PBS and once with PBS containing
20 mM 
 
N
 
-ethyl maleimide (NEM, prepared fresh; Sigma). The cells were
incubated for 20 min on ice in PBS with NEM, scraped from the dish and
pelleted at 1,500 rpm in a Hereaus minifuge for 10 min. The pellet was re-
suspended in 300 
 
m
 
l of 1
 
0 mM Tris-Cl, pH 9, containing NEM and broken
in a 2-ml dounce homogenizer by 12 strokes. The nuclei were removed by
a 2-min spin at 2,000 rpm in an eppendorf centrifuge. To isolate NEM-
treated WR, four 175-cm
 
2
 
 flasks of HeLa cells were infected at low MOI
for 2 to 3 d. PNS of infected cells was prepared as above, the PNS was
loaded on top of 8 ml of a 36% (wt/vol) sucrose cushion in 10 mM Tris-Cl,
pH 9, and the virus pelleted by centrifugation in a SW40 rotor at 24 krpm
for 30 min. The pellet was resuspended in 10 mM Tris-Cl, pH 9, containing
20 mM NEM. PNS or virus were loaded onto 15% SDS-PAGE after boil-
ing for 3 min in LSB with or without 5% 
 
b
 
-ME and 100 mM DTT, the pro-
teins blotted unto nitrocellulose and detected as described (13).
 
[
 
3
 
H]NEM Labeling
 
To 10 
 
m
 
l of a purified virus preparation (with a protein concentration of 2 
Krijnse Locker and Griffiths 
 
Vaccinia Virus Disulfide Bonds
 
269
 
mg/ml or 30 OD
 
260
 
/ml; 26) diluted in 165 
 
m
 
l of 10 mM Tris-Cl, pH 9, 10
 
m
 
Ci of [
 
3
 
H]NEM (Amersham) was added and the mixture incubated on
ice for 20 min. To terminate the labeling, 40 
 
m
 
l of freshly prepared 100
mM NEM in 10 mM Tris-Cl, pH 9, was added and the virus spun for 30
min at 65 krpm in a TLA 100.2 tabletop centrifuge. The pelleted virus was
resuspended in 40 
 
m
 
l sample buffer containing 5% 
 
b
 
-ME. 5 
 
m
 
m of
[
 
3
 
H]NEM-labeled virus was loaded on 15% SDS-PAGE and analyzed by
autoradiography. [
 
35
 
S]methionineÐlabeled and purified virus was made as
before (8). Labeled proteins were immunoprecipitated from 
 
35
 
S-labeled
virus as followed; to 100 
 
m
 
l of labeled virus SDS was added to a final con-
centration of 1% and incubated for 30 min at 37
 
8
 
C. Samples were diluted
in lysis buffer (32) to a final concentration of 0.1% SDS and proteins im-
munoprecipitated from them using specific antibodies. To demonstrate
that NEM had access to intracellular viruses, HeLa cells were infected for
two 2 d, washed twice with ice-cold PBS, and washed twice PBS with or
with 20 mM NEM. The cells were incubated for 20 min on ice in PBS with
or without NEM, scraped, and collected by pelleting. PNS was prepared
as above in 10 mM Tris-Cl, pH 9, with or without NEM and the virus con-
centrated by pelleting through a sucrose cushion as described above. The
pelleted virus was resuspended in Tris-Cl, pH 9, without NEM. 3 and 8 
 
m
 
g
of total protein (as determined by OD
 
260
 
 measurement; see 28) of virus
preparation from NEM or non-NEM-treated cells were labeled with 5 
 
m
 
Ci
of [
 
3
 
H]NEM as above. Equal amounts of virus as used for the [
 
3
 
H]NEM
labeling were analyzed in 15% SDS-PAGE and the proteins detected by
silver staining (26).
 
PulseÐChase Experiments
 
HeLa cells grown in 3.5-cm dishes were infected with a multiplicity of in-
fection (MOI) of 10. At 5.5 h after infection the cells were incubated for
30 min in DME without methionine (Sigma), and when indicated with or
without 5 mM DTT. The cells were pulse-labeled for indicated times with
50 
 
m
 
Ci per dish of [
 
35
 
S]methionine (Amersham) and chased in DME with
5% FCS. After the labeling the cells were washed twice with ice-cold PBS,
once with PBS-20 mM 
 
N
 
-ethyl maleimide (NEM), incubated for 20 min
on ice in PBS with NEM, lysed in detergent solution with NEM and pro-
cessed for immunoprecipitation as described (32).
 
Protease Digestion of Virus and PNS
 
Protease digestion of purified virus preparations was essentially as previ-
ously described (51). In brief, purified virus was diluted in 10 mM Tris-Cl,
pH 9, and mixed with an equal volume of a two times concentrated trypsin
solution. After digestion for 30 min at 30
 
8
 
C, aprotinin was added to a final
concentration of 4 
 
m
 
g/ml and the samples spun for 30 min at 4
 
8
 
C at full
speed in an Eppendorf centrifuge. Both the supernatant and the pellet
were analyzed in 10% SDS-PAGE and the proteins detected by Western
blots. Protease digestion of PNS was as described in Salmons et al. (51).
After digestion and addition of aprotinin, the digested samples were cen-
trifuged for 30 min at 150,000 
 
g
 
. Supernatant and pellet were analyzed by
Western blots and ECL.
 
DTT Treatment of Infected HeLa Cells
 
HeLa cells grown to confluency in two parallel dishes were infected with
an MOI of 10. At 4 h after infection the medium was replaced with new
medium with or without 5 mM freshly prepared DTT. Medium was re-
placed each hour with or without freshly prepared DTT. For EPON em-
bedding the cells were fixed at 8 h after infection and embedded as de-
scribed (13). For the isolation of virions grown in the presence or absence
of DTT, at 6 h after infection the medium was replaced by one volume of
DMEM/5% FCS and 1 vol of MEM without methionine containing 50
 
m
 
Ci of [
 
35
 
S]methionine with or without DTT. This medium was replaced
each hour with medium with or without DTT containing 50 
 
m
 
Ci [
 
35
 
S]me-
thionine until 9 h after infection. To remove unpenetrated virus, cells were
rinsed extensively with cold PBS (or when indicated cold PBS with 20 mM
NEM) and incubated for one hour on ice with 0.2 mg/ml of trypsin (Wor-
thington Biochemical Corp.) in PBS. Digestion was terminated by the ad-
dition of aprotinin (Sigma) to a final concentration of 0.4 
 
m
 
g/ml. The cells
were squirted from the dish and washed three times with PBS/aprotinin.
The cells were broken by 10 strokes in a dounce homogenizer in 10 mM
Tris-Cl, pH 9, and nuclei removed by centrifugation at 2,000 rpm in a
Hereaus minifuge for 5 min. The PNS was layered on top of a 36% su-
crose (wt/vol) cushion in 10 mM Tris-Cl, pH 9, and the virus pelleted by
centrifugation of 30 min at 24 krpm in a SW40 rotor. The pellet was resus-
pended in 10 mM Tris-Cl, pH 9.
 
Negative staining EM after immunolabeling of the particles isolated
from nontreated or DTT-treated cells was performed as described (13).
 
Plaque Assays and Immunofluorescence
 
Equal amounts of TCA precipitable counts of viruses from untreated or
DTT-treated cells were diluted in 2 ml of serum-free DME and serial 10-
fold dilutions were made. The dilutions were plaque-titrated on BSC-40
cells, cells fixed at 48 h after infection and the plaques counted. The titer
was expressed as plaque forming units (PFU) per 1,000 cpm or as PFU per
ml. HeLa cells grown on 11-mm-diam coverslips were infected with an
MOI of 5, 10, and 20 for 60 min at 37
 
8
 
C, the inoculum was removed and
replaced by DME with 5% FCS. The cells were fixed at 6 h after infection
by a 4-min incubation at 
 
2
 
20
 
8
 
C in methanol. The synthesis of viral late
proteins was detected by indirect immunofluorescence using the anti-core
antibody at 1:1,000 and donkey antiÐrabbit coupled to FITC (Dianova:
Jackson ImmunoResearch Labs) at 1:150. Viral DNA was labeled using
Hoechst (Sigma) at 5 
 
m
 
g/ml. The percentage of infected cells was calcu-
lated as follows: of each fixed coverslip 50 cells were counted. They were
considered positive by immunofluorescence if the anti-core antibody
clearly labeled perinuclear structures typical of viral factories. They were
scored DNA-positive, if clear cytoplasmic DNA labeling was detected.
 
Entry Experiments
 
For the entry experiments, WR was propagated in four 24 
 
3
 
 24-cm dishes
of HeLa cells and purified as described by Jensen et al. (26). After band-
ing the isolated virus in a 25Ð40% (wt/vol) sucrose gradient, the virus band
was collected by fractionation and the fractions containing the virus was
determined by a Biorad protein assay. The peak fractions were pooled
and titered by plaque assay (generally the titer was 
 
z
 
5 
 
3
 
 10
 
7
 
 to 10
 
8
 
 PFU/ml).
For the entry assay HeLa cells were grown in 3.5-cm dishes, washed once
with cold DME containing 20 mM Hepes, pH 7.4, and left on ice in this
medium for 10Ð20 min. Virus (on the average an MOI of 10Ð20 was used)
was diluted in 800 
 
m
 
l of DME with Hepes, sonicated for 1 min and cooled
on ice. The virus was applied to the cooled cells and left for 60 min on ice.
The dishes were then incubated for 60 min at 37
 
8
 
C, put on ice and washed
twice with PBS and once with PBS/NEM. The cells were incubated for 60
min on ice in PBS containing 0.2 mg/ml of trypsin to remove unpenetrated
virus from the plasma membrane. The trypsin digestion was terminated by
adding 0.4 
 
m
 
g/ml of aprotinin (Sigma). After 10 min of incubation the cells
were gently squirted off the dishes and collected by centrifugation for 30 s
at 6,000 rpm in an Eppendorf centrifuge. The pellet was washed three
times with PBS containing aprotinin. Subsequently, the cells were resus-
pended in 300 
 
m
 
l 10 mM Tris-Cl, pH 9, containing aprotinin and broken by
10 strokes of a dounce homogenizer. The nuclei were removed and the
proteins concentrated by acetone precipitation overnight at 
 
2
 
20
 
8
 
C. The
samples were run on 15% SDS-PAGE and the proteins detected by West-
ern blotting.
 
Measurements of the Total Intracellular the
GSH/GSSG Concentrations
 
For the determination of the total intracellular GSH and GSSG concen-
trations EllmanÕs reagent was used. 5 
 
3
 
 10
 
7
 
 HeLa spinner cells were in-
fected at an MOI of 10 or mock infected. At 20 h after infection the cells
were washed with PBS and collected by a centrifugation for 10 min at
1,500 rpm. Pelleted cells were resuspended in 300 
 
m
 
l of water and broken
in a dounce-homogenizer and the nuclei removed. EllmanÕs reagent and
NADPH (both from Sigma) were dissolved at 1 mg/ml and 4 mg/ml, re-
spectively, in 1% NaHCO
 
3
 
. Subsequently, they were diluted to a final con-
centration of 0.13 mg/ml (EllmanÕs) and 0.1 mg/ml (NADPH), respec-
tively, in 0.1 M phosphate buffer, pH 7, containing 1 mM EDTA. To 900 
 
m
 
l
of this latter mixture 100 
 
m
 
l of sample or standard (see below) was added
and 10 
 
m
 
l of glutathione-reductase (Boehringer) that was diluted 1:10 just
before use in phosphate buffer/EDTA. Subsequently, the increase in
OD
 
412
 
 was measured over a period of 3 min. As a standard a known con-
centration of GSSG was used. To determine the GSSG concentration
only, PNS of infected or uninfected HeLa cells was prepared after pre-
treating the cells with 10 mM NEM.
 
Results
 
vv Membrane Proteins form Disulfide-bonded Dimers
 
Since previous papers describing the disulfide bonding of 
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vv proteins omitted to use an alkylating reagent before cell
lysis and virus isolation, it could not be excluded that the
observed disulfide bonds were due to an artifactual post-
lysis oxidation of the proteins. Throughout this study we
therefore used the alkylating reagent NEM before cell ly-
sis. Disulfide bonding was analyzed under three different
conditions of infection. First, IMV was isolated and puri-
fied using our standard protocols, except that the infected
cells were treated with NEM (or iodoacetamide; data not
shown) before lysis, in order to assess the disulfide bond-
ing as it occurred in the (isolated) IMV. Second, cells were
infected in the presence of rifampicin, a drug that revers-
ibly blocks the IMV formation at an early assembly stage
but does not interfere with the synthesis of late proteins
(40); this allowed us to assess whether or not the disulfide
bonding depended on IMV assembly. Finally, cell lysates
were also prepared from infected cells that were not
treated with rifampicin to study the vv proteins in the in-
fected cells at all stages of assembly.
The membrane proteins p21, p16, and p32 (see Fig. 1
and Table I) appeared to form disulfide-bonded dimers
under all three conditions, since they occurred in mono-
mer and dimer forms under nonreducing conditions (Fig. 2
a). The amount of dimer formation was somewhat vari-
able; in the case of p21 and p16 
 
z
 
50% of the protein
dimerized (see also below) while of p32 no more than 30%
of the protein was in the dimer form. As noted before (48,
49, 55), the dimers of both p16 and p21 migrated at molec-
ular masses that were smaller than the sum of two mono-
mers. We presume that this is a consequence of a folded
conformation of the dimer and not due to heterodimeri-
zation. By two-dimensional (2-D) gel analysis we have
shown before that the dimers of p21 and p16 run at the
same pI as their respective monomers (26). Since het-
erodimer formation would result in a shift of the pI rela-
tive to the monomeric protein, these 2-D gel data show
that both proteins form homodimers.
In contrast to these three proteins, the migration of p35
was not altered when comparing reducing to nonreducing
gels, arguing that this membrane protein does not form
disulfide bonds (Fig. 2 a). The migration of this latter pro-
tein, however, varied slightly when comparing e.g., the
rifampicin-blocked cell lysates to the IMV. The reason of
these variations in molecular mass are presently not clear.
The dimers of p21 and p16 (but not of p32, or the disul-
fide bonded forms of the core proteins; see below) were
highly resistant to reduction (see also 48, 49); boiling in
sample buffer containing 5% 
 
b
 
-mercaptoethanol only re-
sulted in little reduction of their dimers. Addition to the
standard sample buffer of higher concentrations of SDS or
urea (up to 4 M), replacing 
 
b
 
-ME by freshly prepared
DTT or increasing the boiling time also did not result in a
quantitative reduction of either p21 or p16 (not shown).
For reasons we do not understand, the most complete re-
Figure 1. Schematic representation of the IMV structure. The
brick-shaped core in the central part is made up predominantly
by the proteins 4a, 4b, p25, and p11. The core is studded with a
layer of spikes that consists at least in part of the p39 protein. The
particle is surrounded by two cisternal membrane layers that we
believe do not fused with themselves (which is depicted in this
figure as a hypothetical overlapping of the cisternal membranes).
The inner of the two membranes contains mainly p21 and p16,
the outer p35, p32, p8, and the peripheral membrane protein p14
(see also 50). In this model the cisternal envelope is akin to the
two membranes of the nuclear envelope, continuous but distinct
in protein composition.
 
Table I. Overview of the Main vv Proteins Described in
This Study
 
Name Molecular mass* Gene Location
 
à
 
Reference
 
p16 15Ð16 kD A14L M 49
p21 23Ð25 kD A17L M 47
p32 32 kD D8L M 38, 43
p35 35 kD H3L M 4
4a 65 kD A10L C 59
p25 25 kD L4R C 61
p39 40Ð45 kD A4L C 39
 
*Predicted molecular mass in SDS-PAGE of the monomeric (and mature) form of the
proteins.
 
à
 
Location in the virion; M, membrane; C, core.
Figure 2. Western blots of vv
proteins analyzed under re-
ducing and nonreducing con-
ditions. In A analysis of four
IMV membrane proteins,
p21 (A17L), p16 (A14L), p35
(H3R), and p32 (D8L). Cell
lysates of infected HeLa cells
treated (F) or not treated (L)
with rifampicin or purified
virus (V) were run on 15%
SDS-PAGE. Before electro-
phoresis the samples were
boiled for 3 min in LSB with
(R) or without (NR) 5% b-ME
and 100 mM DTT. The pro-
teins were detected by West-
ern blotting using the respec-
tive antibodies. On the right
side of the figure the posi-
tions of the 54-, 38-, and 34-
kD marker proteins is in-
dicated. In B, three vv core
proteins 4a (A10L), p39
(A4L), and p25 (L4R) were
analyzed as described in A.
Note that in rifampicin-
blocked cell lysates for both
4a and p25 only their precur-
sor form (of 110 and 28 kD, respectively) can be detected that is
subsequently cleaved to the 65- and 25-kD mature forms, respec-
tively, in the IMV. Some of the uncleaved form, can however,
still be detected in the isolated virions. The positions of the 130-,
66-, 54-, 38-, and 34-kD marker proteins are indicated on the
right. 
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duction of these two proteins was obtained by using a mix-
ture of 5% 
 
b
 
-ME and 100 mM freshly prepared DTT (see
Discussion).
Taken together, these data show that three vv mem-
brane proteins form disulfide bonded dimers, in early vac-
cinia membranes as well as in the mature IMV.
 
vv Core Proteins Are Disulfide Bonded in the IMV Only
 
Next, we used the same approach to analyze some of the
vv core proteins. In contrast to the three membrane pro-
teins, the core proteins 4a, p25, and p39 (Fig. 1 and Table
I) occurred only in their reduced form when the IMV for-
mation was blocked (in rifampicin-blocked cell lysates;
Fig. 2 b). However, in the purified IMV (and to some ex-
tent in cell lysates that had not been blocked with rifampi-
cin) these three core proteins appeared to form disulfide
bonds. This was most obvious for p39, whose migration
was clearly faster in IMV analyzed under nonreducing
conditions. The faster migration of the unreduced versus
the reduced protein is typical for intramolecular disulfide
bonding, resulting from a more folded conformation of the
oxidized form (for example see 1).
In infected cells both p25 and 4a are initially made as
precursors of 28 and 110 kD, respectively, which are sub-
sequently cleaved upon IMV formation into their mature
forms of 25 and 65 kD, respectively (57, 58). Indeed, in
rifampicin treated cell lysates both proteins migrated at
the position of their precursor form and the migration of
both proteins was the same when analyzed with or without
prior reduction. However, in the IMV the mature forms of
these two proteins showed additional bands when ana-
lyzed without reduction. The protein 4a occurred both as a
monomer of 65 kD, as well as a dimer of 
 
z
 
130 kD when
 
b
 
-ME and DTT were omitted from the sample buffer (Fig.
2 b). That the dimer indeed ran at 
 
z
 
130 kD can be better
appreciated in Fig. 8, where 4a was analyzed in a 10%
SDS-PAGE (see below). After reduction 4a migrated pre-
dominantly in its (reduced) mature form of 65 kD, while
the 130 kD band was clearly absent. Two additional bands
were seen in this reduced sample, the upper one repre-
sents the uncleaved precursor, p4a (note the comigration
of this band with the form made in rifampicin-blocked cell
lysates), of which small amounts can be detected in mature
virions, while the identity of the lower of the two remained
open. When analyzing p25 in isolated virions under nonre-
ducing conditions the protein showed a very unusual pat-
tern and appeared as several (disulfide bonded) species
some of which migrated as a smear rather than discrete
bands (Fig. 2 b). When analyzed after reduction, the pro-
tein migrated predominantly at the position expected for
its mature 25-kD form, but also, as for 4a, some of the un-
cleaved precursor could still be detected.
Collectively, these results show that the vv core proteins
are also able to make disulfide bonds, but in contrast to
the membrane proteins, do so only in the assembled IMV.
 
[
 
3
 
H]NEM Labeling Shows That NEM Has Access to vv 
Core Proteins
 
The above results strongly suggest that vv membrane and
core proteins form disulfide bonds. Care was taken in each
of these experiments to incubate the infected cells at least
 
20 min with NEM on ice before cell lysis, thus excluding
the possibility that the disulfide bonding resulted from
post-lysis oxidation. However, the mature IMV is a highly
compact structure and we had to rule out that NEM might
not have access to vv proteins, especially to those within
the viral core. Therefore, we performed two experiments
to address this issue. First, isolated and purified IMVs
were labeled with [
 
3
 
H]NEM for 20 min on ice and the labeled
protein pattern compared with [
 
35
 
S]methionine-labeled
virions. [
 
3
 
H]NEM labeling showed a discrete pattern of
bands, the most abundant of which comigrated with the
core proteins 4a, p11, and p25 (Fig. 3 a). Some of the other
minor bands were identified as p21, p16, and p35 (not
shown). The [
 
3
 
H]NEM labeling of both p21 and p16 in-
creased significantly when the IMV was treated with DTT
before the labeling (not shown).
To demonstrate that NEM also had access to the viral
proteins in infected cells we carried out the following ex-
periment. Infected cells were incubated with or without
20 mM NEM on ice before lysis. Subsequently, a PNS was
prepared either in the presence or absence of NEM and
Figure 3.[ 3H]NEM has ac-
cess to the viral core pro-
teins. In A, isolated and puri-
fied IMVs were labeled for
20 min on ice with [3H]NEM
(3H). Infected cells were la-
beled for 3 d with [35S]me-
thionine and the labeled viri-
ons isolated and purified
(35S).  35S-labeled virions
were disrupted by incubation
for 30 min at 378C with 1%
SDS and subsequently di-
luted in lysis buffer to a final
concentration of 0.1% SDS.
From these lysed particles
the protein 4a (4a), p25
(p25), and p11 (p11) were
immunoprecipitated. Analy-
sis was on 15% SDS-PAGE
followed by autoradiogra-
phy. M-14C-labeled marker
proteins of 14, 30, 45, 69, 93,
and 200 kD. In B, infected
cells were treated (NEM 1)
or not treated (NEM 2) with
20 mM NEM for 20 min on ice before the preparation of PNS in
buffer with or without NEM. The virions were concentrated by
pelleting through a sucrose cushion at 24 krpm in a SW40 rotor
for 30 min. Pellets were resuspended in buffer without NEM.
Equal amounts of pelleted virions were incubated with 5 mCi of
[3H]NEM and the labeled virions analyzed on 15% SDS-PAGE
followed by autoradiography. In the left lane (of 1 or 2 NEM) 3
mg of total protein, in the right lane 8 mg of protein was used for
[3H]NEM labeling. 35S virus control lane consisting of [35S]me-
thionine-labeled, purified virions. M-14C-labeled marker proteins
of 69, 45, 30, and 14 kD. In C, the same amounts of virions as used
for the [3H]NEM labeling (3 mg of protein [left] and 8 mg [right],
respectively) isolated from cells that were pretreated (NEM 1)
or not pretreated (NEM 2) with NEM were run on 15% SDS-
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the virions were concentrated from it by pelleting through
a sucrose cushion. This pelleting step also served to sepa-
rate the virions from unbound NEM. The pelleted viruses
were then resuspended in NEM-free buffer and labeled on
ice with [3H]NEM. As shown in Fig. 3 b, IMVs isolated
from untreated cells were readily labeled with [3H]NEM
and showed the same characteristic labeling pattern as in
Fig. 3 a. In contrast, when infected cells were incubated
with NEM before virus isolation, the virion were not la-
beled at all by [3H]NEM. The corresponding silver stained
gel of the same virion preparations showed that the ab-
sence of labeling was not due to a lack of (viral) proteins
(Fig. 3 c). We interpret these results to mean that upon
preteatment of infected cells with (cold) NEM, this com-
ponent readily binds to viral proteins, efficiently inhibiting
the subsequent [3H]NEM labeling.
In conclusion, these data show that NEM has readily ac-
cess to viral (core) proteins both in purified virions as well
as in infected cells. This also rules out that the IMV could
form artifactual disulfide bonds by a post-lysis oxidation in
our experiments.
Kinetics of Disulfide Bonding
We next asked whether the vv disulfide bonds were built
up concomitant with, or after protein synthesis. For this
we chose to follow the kinetics of dimer formation of p16.
This protein has been shown to be a very abundant mem-
brane protein of the IMV that inserts into RER in a
cotranslational manner and is retained in the IC in in-
fected cells (51).
Infected cells were pulse-labeled at 6 h after infection
and chased for up to 4 h. Small amounts of the dimer of
p16 were first detected after 60 min, but was seen more
clearly at 2 h of chase. At 4 h of chase z50% of p16 was in
the dimer form (Fig. 4). The band migrating intermediate
between the monomer and the dimer of p16 is due to the
addition to some of N-linked glycosylation to a fraction of
the molecules (Krijnse Locker, J., manuscript in prepara-
tion). A similar analysis of the core protein p39 showed
that its disulfide bonding also occurred posttranslationally.
The half time of its formation was z2 h, similar to the half
time of IMV formation (data not shown).
These data show that disulfide bonding occurs post-
translationally, adding further support to the evidence that
they do not arise from artifactual post-lysis oxidation.
The Unique Cysteine of p32 Is Exposed on the Surface 
of the Virus as Well as in the Cytosol
Previous detailed analyses of the topology of the mem-
brane proteins p21 and p16 strongly suggested that their
relevant cysteines were not, as expected, exposed towards
the lumen but are most likely on the cytosolic side of
the membrane. For instance, we have proposed that p21
crosses the membrane four times, exposing its NH2 and
COOH terminus towards the cytoplasm (34). If this topol-
ogy is correct, p21 exposes two of its three cysteines (at po-
sitions 101 and 178) into the cytoplasm while its third cys-
teine (at position 131) is buried in the membrane (34).
However, the possibility that p21 may span the membrane
twice instead of four times, thereby exposing its cysteine at
position 101 towards the lumen (where it could potentially
dimerize with itself) cannot be excluded at present.
According to the previously proposed topology of p16,
this protein spans the membrane twice and appears to
adopt two different orientations in the membrane; one in
which the NH2 and its 22Ðamino acid long COOH termi-
nus (which includes both its cysteine at position 71 and a
functional N-glycosylation site) are lumenal and one with
the opposite orientation (51; Krijnse Locker et al., manu-
script in preparation). That p16 may adopt two different
topologies in infected cells was based on two independent
pieces of evidence. First, using two different morphologi-
cal assays we were able to show that a considerable frac-
tion of p16 exposes the COOH terminus towards the cyto-
sol (51). Second, since p16 is also partially N-glycosylated,
its COOH terminus (that contains the N-glycosylation
site) must also be exposed towards the lumen. A recently
developed assay to quantitate the two different topologies
of p16 in infected cells (Krijnse Locker and Griffiths,
manuscript in preparation), showed that z50% of the di-
sulfide bonded dimer of p16 exposes its COOH terminus
towards the cytoplasm, implying that disulfide bonding of
this protein occurs, at least in part, on its cytoplasmic do-
main.
Hydrophobicity plots of p32 revealed a single hydropho-
bic segment of 20 amino acids in its extreme COOH termi-
nus that could serve as membrane-anchor (38). Thus, the
protein seems to belong to a recently described class of
membrane proteins with COOH-terminal hydrophobic do-
mains that insert posttranslationally, thereby exposing
most of their NH2 terminus towards the cytoplasm (35). If
p32 inserts into the membrane accordingly, the protein
would expose its single cysteine in the NH2 terminus at po-
sition 262 towards the cytoplasm as well as on the outer
surface of the IMV (see also 54). To test this possibility,
we carried out two different set of experiments. First, puri-
fied IMV was treated with increasing concentrations of
trypsin and the digestion of p32 was assayed by Western
blot using an antibody recognizing amino acid 77 to 294
Figure 4. Disulfide bonding occurs posttranslationally. Infected
HeLa cells were pulse-labeled (0 min chase) for 2 min at 6 h after
infection and chased for the indicated time. Cell lysates were pre-
pared and the p16 protein immunoprecipitated from them. The
samples were run on 15% SDS-PAGE after boiling for 3 min in
LSB with or without b-ME and DTT. The proteins were detected
by autoradiography. After the pulse only the monomeric p16 is
seen. After 60 min of chase the disulfide bonded dimer is de-
tected as assessed by the absence of the 25-kD band when ana-
lyzed after reduction. The band migrating with a molecular mass
between the monomer and the dimer is a N-glycosylated form of
p16 that will be described elsewhere (Krijnse Locker, J., manu-
script in preparation). M-14C-labeled marker proteins, of which
the 14- and 30-kD proteins are indicated.Krijnse Locker and Griffiths Vaccinia Virus Disulfide Bonds 273
(43). Under conditions in which the internally located core
protein 4a was completely protease-protected, the entire
population of both the dimer as well as the monomer of
p32 were digested (Fig. 5 a). In fact, after pelleting the
IMV from the digestion mixture, a new 28-kD fragment
that was recognized by the p32 antibody was now detected
in the supernatant, while the digested virion was totally
devoid of immunoreactive p32 protein (Fig. 5 a). The well
characterized peripheral membrane protein p14 was com-
pletely digested even at the lowest protease concentration
tested and no protected fragment was detected in the su-
pernatant.
In a second set of experiments, post-nuclear superna-
tants of infected cells that were treated with rifampicin (to
block virion formation), were digested with trypsin. Subse-
quently, the membranes were pelleted and the digestion of
p32 followed by Western blots. In these experiments we
made use of a vv recombinant expressing the mouse hepa-
titis virus (MHV) M protein as a control. The topology of
this latter membrane protein has been well established, ex-
posing its extreme COOH terminus of z18 amino acids
towards the cytoplasm and its NH2 terminus lumenally
(32). Indeed, with increasing concentrations of trypsin, re-
activity to a peptide antibody raised against the COOH-
terminal 18 amino acids of the MHV-M protein was
completely lost (Fig. 5 b). In contrast, at all trypsin con-
centrations tested, the antibody to the NH2 terminus rec-
ognized the characteristic triplet representing the unglyco-
sylated and two of the O-glycosylated forms of M (see also
33), showing that the membranes were intact (Fig. 5 b).
When analyzing p32 under the same conditions, both the
dimer as well as the monomer were completely digested.
However, the same 28-kD fragment that was observed for
the virus (see also 43), was again found in the supernatant,
apparently released from the membranes (Fig. 5 b).
These experiments show that the entire NH2 terminus is
not only exposed on the surface of the IMV, but also into
the cytoplasm of infected cells. Since its single cysteine at
position 262 is contained in this part of the molecule, it fol-
lows that disulfide bonding of p32 must occur on its cyto-
plasmic domain that is exposed on the surface of the IMV.
Together with the available data on p21 and p16, these re-
sults suggest that cytosolic disulfide bonding may be a
common feature of vv membrane proteins.
In the Presence of 5 mM DTT IMVs Are Formed That 
Are Less Stable
To address the possible function of the disulfide bonds in
the IMV, it was necessary to reversibly inhibit their forma-
tion in infected cells. For this, advantage was taken of a
previously described observation that the addition of 5 mM
DTT to living cells not only keeps newly synthesized mem-
brane proteins reduced but is also capable of reducing al-
ready oxidized proteins residing in the ER (2). 4 h after in-
fection 5 mM DTT was added to one dish of cells, while a
parallel dish was kept free of DTT. 4 h after infection was
chosen since this time point is about one hour before the
onset of viral assembly. At 8 h after infection the cells
were fixed, embedded into Epon and the IMV-formation
was assessed by EM. Since the DTT incubations were
done over relatively long periods of time, the medium of
the cells was replaced each hour with medium to which
freshly prepared DTT was added just before use.
At first glance, the addition of DTT had no obvious ef-
fect on IMV assembly, since by thin section EM we readily
observed many apparently normal looking immature vi-
ruses (IVs), intermediates and IMVs (Fig. 6; see 53). How-
ever, upon closer examination a substantial fraction of
IMVs could be detected that resembled virions in various
stages of apparent disassembly (Fig. 6, bÐf). Profiles were
seen of particles in which the membranes had become less
rigid and detaching from the underlying core. Occasionally
we also observed particles indistinguishable from viral
Figure 5. The NH2 terminus of p32 is exposed on the IMV sur-
face and towards the cytoplasm of infected cells. (A) Purified
IMV was treated for 30 min at 308C with the indicated concentra-
tions of trypsin. Digested IMV was pelleted by a 30-min centrifu-
gation at 15,000 g. The pelleted virus (pellet) and the remaining
supernatant were analyzed on 10% SDS-PAGE followed by
Western blots using antibodies to p32, 4a, and p14. P14 and 4a
were analyzed after reduction while p32 was analyzed under non-
reducing conditions only. The position of the monomer of p32 is
indicated with one and that of the dimer with two asterisks. (B)
Post nuclear supernatants of rifampicin-treated cells infected
with a vv recombinant expressing the MHV-M protein were pre-
pared at 7 h after infection. PNS was treated with the indicated
concentrations of trypsin at 308C for 30 min. Supernatant was
separated from the membranes (pellet) by a centrifugation for 30
min at 150,000 g and both fractions were analyzed on 15% SDS-
PAGE. The proteins were detected by Western blots using anti-
bodies to p32, the NH2 (M-N) or COOH terminus (M-C) of the
MHV-M protein. The unglycosylated (M0) and glycosylated
forms (M3 and M4) of the M protein are indicated (see also 33).
Note that the COOH-terminal specific peptide serum recognizes
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cores (not shown). Compared with the control cells, IVs
and intermediates (53) appeared totally normal. None of
these aberrant particles with detaching membranes or na-
ked cores could be detected in the untreated control cells,
implying that they resulted from the prolonged DTT incu-
bation.
These results argue that in the presence of DTT mostly
normal looking IMVs are formed, but in some the mem-
branes fail to assemble compactly around the core.
Cleavage of the Core Protein 4a Shows that in the 
Presence of DTT the IMV Formation Occurs with the 
Same Kinetics
In the final stage of IMV assembly, just before the IMV
closure, at least three core proteins are proteolytically
cleaved (30, 41). Estimation of the cleavage of the precur-
sor of a protein such as the core protein 4a using pulseÐ
chase experiments can thus be used as an indirect measure
of the extent of IMV formation. To test the effect of DTT
on IMV assembly using this assay, infected cells were left
untreated or treated with DTT from 4 h after infection on-
wards. Subsequently, they were pulse labeled for 15 min at
6 h after infection, chased for 2 or 3 h and cell lysates were
then processed for immunoprecipitation, using antibodies
to 4a and its precursor. Again, during the course of this ex-
periment the medium was replaced several times with me-
dium containing freshly prepared DTT (see legend to Fig.
7). As shown in Fig. 7 both in the presence and absence of
DTT the precursor p4a of 110 kD was efficiently cleaved
into its 65-kD mature form (4a) during the chase. Phos-
phorImager analyses showed that, consistent with previ-
ously published results (41; Fig. 7), after 2 h of chase 35%
of 4a was cleaved in the absence and 40% in the presence
of DTT, while these percentages amounted to 48 and 57%,
respectively, after 3 h of chase (not shown). These same
analyses also showed that the overall synthesis of 4a was
reduced by z40% in the presence of DTT, which is most
likely the result of the long incubations with this drug. Im-
portantly, however, 4a and p4a did not seem to undergo
substantial degradation, suggesting that the newly formed
cores were quite stable, both with and without DTT.
Although this experiment suggests that in the presence
of DTT less IMVs are formed, it also shows that the kinet-
ics of IMV assembly is the same, if not slightly faster than
in untreated control cells.
Thus, by two independent assays, 5 mM DTT does not
appear to significantly affect the assembly of the IMV.
Addition of DTT to Infected Cells Prevents the 
Formation vv Disulfide Bonds
The above results implied that the vv-disulfide bonds may
have no obvious role in IMV formation, although they
might be required for the tight sealing of the vv mem-
branes around the particle. A possibility that remained to
Figure 6. In the presence of DTT apparently normal looking
IMVs are formed but in some of them the viral membranes de-
tach from the underlying core. A shows Epon sections of control,
untreated HeLa cells infected with vv for 8 h. IMVs and imma-
ture viruses (IVs) are evident. In the inset on the left the outer
and inner membrane profiles of the IMV are indicated by arrows.
The inset on the right shows an intermediate stage between the
IV and IMV (arrowhead) next to a IV. B and C show vv-infected
cells treated with 5 mM DTT from 4 h after infection onwards
and fixed at 8 h after infection (see Results for details). In B, one
sees both normal looking IMVs (star) as well as aberrant IMVs
(arrowheads), where the viral core is seen as a distinct entity sep-
arated from the outer membranes. This is more evident at higher
magnifications in CÐF; in C a normal IV is apparent. The arrow-
heads indicate the viral core that in all these examples appears as
a distinct entity. Bars, 100 nm.
Figure 7. In the presence of
DTT p4a is cleaved to its ma-
ture (4a) form. Infected
HeLa cells were treated
(DTT 1) or not treated
(DTT  1) from 4 h after infection onwards with 5 mM DTT. In
each case, when medium with DTT was applied to the cells,
freshly prepared DTT was added to the medium just before use.
At 5 h after infection the medium was replaced with medium
with or without DTT. At 5.5 h after infection the cells were
starved in methionine-free DMEM with or without DTT. Pulse-
labeling for 15 min (chase 0 h) was at 6 h after infection and con-
sisted of replacing the methionine-free medium by the same me-
dium containing 50 mCi of [35S]methionine with or without DTT.
After the pulse, cells were chased for 2 and 3 h (chase 2 and 3 h)
in medium with or without DTT that was replaced each hour. At
the end of the pulse or chase cell lysates were prepared and 4a
and its precursor form (p4a; both indicated) were immunoprecip-
itated from them. Immunoprecipitates were run on 10% SDS-
PAGE and the proteins detected by autoradiography. M-14C-
labeled marker protein of 93 kD.Krijnse Locker and Griffiths Vaccinia Virus Disulfide Bonds 275
be ruled out was that the disulfide bonds of vv proteins
might resist the DTT treatment. We decided therefore to
isolate the virions from infected cells and to analyze the
disulfide bonding of their proteins. For this, infected cells
were left untreated or were treated with DTT from 4 until
9 h after infection and IMVs were isolated after extensive
washing of the cells with PBS containing NEM to quench
the DTT. Again during the 5-h DTT treatment the me-
dium with DTT was replaced every hour with medium
containing fresh DTT. After virus isolation the disulfide
bonding of selected membrane and core proteins was ana-
lyzed by Western blots. DTT indeed had its expected ef-
fects on the vv proteins; the core proteins 4a, p25 as well as
the membrane proteins p21 and p16 migrated in their re-
duced form only in particles isolated from DTT-treated
cells (Fig. 8). As expected, in the virions from control cells
the same pattern of disulfide bonding was observed as de-
scribed above (Fig. 8). Since in this particular experiment
we used 10% instead of 15% SDS-PAGE, the dimer of 4a
was much better separated from its monomer. Again,
small amounts of the precursor of 4a were present in this
virus preparation and it is more evident in this analysis
that the dimer of 4a is substantially larger than the 110-kD
precursor form.
When the particles isolated from DTT-treated cells were
examined by negative staining EM, we observed that most
of them were not intact (in contrast to untreated prepara-
tions where most of them were intact). By combining this
approach with immunogold labeling using specific anti-
bodies, we found that almost all of the isolated particles
appeared to have lost or opened up their membranes. The
brick-shaped particles from DTT-treated cells, labeled
heavily for p39, an abundant antigen on the surface of the
vv core (Fig. 9, a and d; 8, 50), while IMV particles isolated
from nontreated cells (as expected; 8) could not be labeled
with this antibody (Fig. 9 b). In the particles isolated from
DTT-treated cells, the viral membranes often remained at-
tached to the core and were heavily labeled with antibod-
ies to the membrane protein p16. We have shown before
that in intact IMVs this protein is located on the inner of
the two cisternal membranes and hidden from antibody
accessibility (Fig. 9 c; see 51).
Thus, while the disulfide bonds may not be essential for
the assembly process in infected cells, they appear to be
necessary for maintaining the stability/integrity of the par-
ticles when released from cells.
Viruses of DTT-treated Cells Are Less Infectious
We next asked whether the particles isolated from DTT-
treated cells were still infectious. To relate the infectivity
to the number of viruses made, infected and DTT-treated
as well as nontreated cells were metabolically labeled from
6 to 9 h after infection and the titers, measured by plaque
assay, were expressed as PFU relative to trichloroacetic
acid-precipitable, radioactive counts. In these experiments
the cells were not quenched with NEM before virus isola-
tion since treatment of the IMV with DTT in vitro, fol-
lowed by NEM or iodoacetamide incubation, completely
abolished infectivity (data not shown). The average of
three independent experiments showed clearly that the
IMV isolated from DTT-treated cells had a title that was
10-fold reduced relative to virus isolated from control cells
(Table II). We have shown before in several studies that
when purified IMV is treated for 30 min at 378C with 20 mM
DTT, the membranes separate in part from the core (see
8, 50, 54). Structurally, this in vitro DTT treatment is very
similar to what we observed with the virions isolated from
DTT-treated cells. We next asked therefore whether iso-
lated IMV treated with DTT in vitro was still infectious.
Remarkably, and in contrast to the virus from DTT-
treated cells, IMV that had been treated in vitro with DTT
Figure 8. The proteins from viruses
isolated from DTT-treated cells are
not disulfide bonded. Infected HeLa
cells were treated (DTT 1) or not
(DTT 2) with 5mM DTT from 4 h
after infection and the medium re-
placed each hour as described in the
Results. 9 h after infection, virions
were isolated from the cells as de-
scribed in Materials and Methods.
Isolated virions were analyzed on
10% SDS-PAGE and the viral pro-
teins p21, p16, 4a, and p25 were de-
tected by Western blotting. Virions
isolated from untreated cells (V2)
were analyzed after boiling in sample
buffer with (DTT 1) or without
(DTT  2) 5% b-ME and 100 mM DTT, while virions isolated
from treated (V 1) cells were only analyzed after boiling in sam-
ple buffer without (DTT 2) these reducing agents. On the right
the positions of the 34-, 38-, 54-, 84-, 116-, and 180-kD marker
proteins are indicated.
Figure 9. Negative staining EM of particles isolated from un-
treated (B) or DTT treated cells (A, C, and D). Particles from in-
fected HeLa cells untreated or treated with DTT were isolated as
described in Materials and Methods. The particles were absorbed
to 300 mesh formvar and carbon-coated grids and immuno-
labeled with antibodies to p39 (A, B, and D) and to p16 (C), fol-
lowed by protein AÐgold. Whereas virions isolated from un-
treated cells are not labeled with p39 (B), the particles from
treated cells label heavily with the antibody (A and D). The anti-
p16 antibody labels fragments that are still attached to the parti-
cles isolated from DTT-treated cells. These fragments often ap-
pear as tubular structures (C). Bars, 100 nm.The Journal of Cell Biology, Volume 144, 1999 276
had the same title (and sometimes even slightly higher; not
shown) as the untreated virus (Table II).
The infectivity of the IMV isolated from treated and
nontreated infected cells was also assayed by Immunoflu-
orescence microscopy. In vv life cycle DNA replication
starts from 2 h after infection onwards, while late protein
synthesis commences at 5Ð6 h of infection. The character-
istic pattern of immunofluorescence at 6 h after infection
is the complete overlap of the sites where viral DNA and
late proteins accumulate. HeLa cells grown on coverslips
were therefore infected with different multiplicity of infec-
tions (MOIs) ranging from 5 to 20 (see Materials and
Methods) and fixed at 6 h after infection. The extent of
infection was assayed by double indirect immunofluores-
cence using an antibody to vv cores (see Materials and
Methods) that recognizes newly synthesized core proteins,
as well as Hoechst dye to label the viral DNA. As ex-
pected, the cytoplasm of all cells were labeled for both
DNA as well as the anti-core antibody when using virus
from untreated cells, even at the lowest multiplicity of in-
fection (Table III). Similarly, when this same virus prepa-
ration was treated with DTT in vitro all cells were infected
at 6 h after infection (data not shown). However, when sim-
ilar amounts of infectious units were used of virus from
DTT-treated cells, even at the highest MOI the amount of
cells showing DNA replication, as well as protein synthe-
sis, was significantly reduced (Table III). More specifi-
cally, we found that, compared with control virus, at an
MOI of 5 the percentage of DNA-positive cells was re-
duced by 73% and late protein-expressing cells by 98%.
Apparently, the infection cycle of these viruses was se-
verely delayed.
During the Early Stages of IMV Infection the Core 
Proteins Become Reduced
Since reduction of the IMV in vitro, as well as in vivo led
to a form of uncoating of the virus, we were curious to
know whether reduction of vv proteins was also required
for disassembly in vivo, that is during the infection pro-
cess. Highly purified IMV stocks were therefore bound to
cells on ice and subsequently shifted to 378C for 1 h.
Bound (but nonpenetrated) particles were removed by
trypsin treatment on ice (see Materials and Methods).
Subsequently, the infected cells were lysed and the vv pro-
teins analyzed under reducing and nonreducing condition
using Western blots. Under these conditions the two core
proteins 4a and p25 migrated exclusively at the position of
the reduced form (Fig. 10). To our surprise, the membrane
proteins p16 and p21 did not appear to become reduced
during early times of infection. Instead both proteins mi-
grated with a slightly higher molecular mass than their re-
spective dimers seen under nonreducing conditions (Fig.
10). When analyzed after reduction these forms of both
p16 and p21 migrated slightly slower than their respective
monomers (Fig. 10). Since by 2-D gel analysis, these newly
generated forms of p21 and p16 appeared to have the
same pI as the proteins in isolated virions (not shown), we
presume that this slower migration is due to a (unconven-
tional) conformational change and not the consequence of
their binding to some other (unknown) protein.
It thus seems likely that either the membrane proteins
of vv are inherently resistant to the reducing environment
of the cytoplasm or they are never exposed to the cyto-
plasm during the entry stage.
Discussion
It is now a well established cell biological dogma that the
redox state within the lumen of the endoplasmic reticulum
facilitates the formation of disulfide bonds while the cyto-
plasm is generally considered to be too reducing for this
process (17, 20, 24). Unexpectedly, we show here that vac-
cinia virus seems to differ from this generalization since a
number of its proteins that do not reside in the lumen of
the ER become disulfide bonded during the assembly pro-
cess.These unusual disulfide bonds were detected not only
on viral core proteins but also on the cytoplasmic surface
of viral integral membrane proteins.
Three vv core proteins were engaged in (posttransla-
Table II. Infectivity of vv Isolated from DTT-treated
or -untreated Cells or after DTT Treatment of Isolated IMV
PFU/1,000 cpm*
Controlà 1.4 3 107
DTT-treated cells 1.9 3 106
Control after DTT treatment 1.5 3 107
*Average titer over three independent experiments, determined by plaque assay on
BSC40 cells.
àControl is IMV isolated from untreated cells.
Table III. Infectivity of vv Isolated from DTT-treated or 
Control Cells Determined by Indirect Immunofluorescence*
MOIà
DNA positive¤ IF positivei
51 02 051 02 0
Control¦ 98% 100% 100% 90% 100% 100%
DTT** 27% 34% 52% 2% 11% 12%
*HeLa cells grown on coverslips were infected with different MOIs for 60 min at
37¡C and fixed at 6 h after infection. The infectivity is expressed as the percentage of a
total of 50 cells that labeled positive for viral DNA or viral late proteins.
àTo calculate the MOI, the virus-titer was calculated as PFU/ml.
¤Fixed cells were stained with Hoechst and scored positive if clear cytoplasmic DNA
labeling typical of viral DNA was observed.
iFixed cells were labeled with a rabbit antibody to the viral core proteins and with
donkey anti-rabbit coupled to FITC and scored positive if typical viral factories in the
perinuclear region could be detected. IF, indirect immunofluorescence.
¦IMV isolated from untreated cells.
**IMV isolated from DTT-treated cells.
Figure 10. Upon viral entry
the core proteins become re-
duced while the membrane
proteins do not. HeLa cells
were infected with purified
virus preparations for 60 min
at 378C and cell lysates were
prepared as described in Ma-
terials and Methods. The cell
lysates (L) or purified virions (V) that were not exposed to cells,
were run on 15% SDS-PAGE after boiling in LSB with (DTT 1)
or without (DTT 2) 5% b-ME and 100 mM DTT. The mem-
brane proteins p21 and p16 and the core proteins 4a and p25
were detected by Western blot.Krijnse Locker and Griffiths Vaccinia Virus Disulfide Bonds 277
tional) intramolecular (p39), intermolecular (4a) and com-
plex type (p25) disulfide bonding. These disulfide bonds
occur in the newly assembled (intracellular) IMV particle
since they are not formed in the presence of rifampicin
which arrests the assembly of the IMV. This is further sup-
ported by the fact that the mature form of the core protein
4a, that is made concomitant with the assembly of the IMV
(30, 31, 41), forms dimers while its cytosolic precursor, p4a
does not. The model that emerges from these results is
that after the vaccinia virus has sealed, it is able to provide
an environment within the particle that promotes the as-
sembly of disulfide bonds of the core proteins, an environ-
ment that is inaccessible to GSH/GSSG, the cytoplasmic
redox buffer. Indeed, treatment in vitro of purified IMV
with concentrations up to 10 mM GSH failed to reduce
the core proteins as analyzed by Western blots (data not
shown).
In addition to the core proteins we also show that three
of the four vv membrane proteins tested, p16, p21, and p32
become disulfide bonded. Our detailed topology studies of
these membrane proteins strongly suggest that these disul-
fide bonds do not (exclusively) occur in the lumen of the
endoplasmic reticulum. In agreement with the data of
Niles and Seto (43) we show that the disulfide bonded
dimer, as well as the monomer of p32 is exposed on the
surface of the IMV. This protein adopts a similar topology
in infected cells in which the entire NH2 terminus, includ-
ing its single cysteine, of both the dimer and the monomer
forms are located in the cytoplasm, since both were com-
pletely digested after protease treatment. These results in-
directly but strongly argue that the disulfide bonding of
this protein must occur on the cytosolic side of the mem-
brane that will become the outer surface of the virus,
where p32 is accessible to antibody labeling (54).
The available data on p16 strongly suggest that this pro-
tein acquires two topologies in infected cells and at least
part of its molecules dimerizes by means of cytoplasmic
disulfide bonds. As mentioned, the available data for p21
are less clear. If the topology we have previously proposed
for this protein is correct, it would span the membrane
four times and also be disulfide bonded in the cytoplasm
(see Results). The disulfide bonding of these membrane
proteins may be an inherent property of the proteins since
it can occur in infected cells under conditions where as-
sembly is blocked (rifampicin) and upon independent ex-
pression in HeLa cells (not shown).
A computer search analysis has revealed that the vv ge-
nome contains 19 proteins with a CXXC sequence, that, as
outlined in the Introduction, makes up the active site se-
quence of proteins with a thioredoxin motif. Two of those
proteins, the gene products of O2L and G4L, have been
shown to share homology to human glutaredoxin (18, 46).
Moreover, we have noticed that the gene product of G4L
also shares z50% homology over a stretch of z50 amino
acids (which includes the CXXC sequence) with yeast
PDI. Preliminary data, however, have shown that neither
of the two vv proteins is required for the disulfide bonding
of vv proteins (data not shown).We also considered the
possibility that the vv infection alters the cytoplasmic re-
dox providing an environment that is more favorable for
the assembly of cytoplasmic disulfide bonds. However, we
were able to show that the ratio between reduced and oxi-
dized glutathione is not altered in infected cells (see Mate-
rials and Methods).
Since the redox state of the cytoplasm of vv infected
cells remains normal, it suggests that those membrane pro-
teins that acquire cytoplasmic disulfide bonds possess an
inherent property to acquire these bonds. In vitro studies
have shown that the formation of intramolecular disulfide
bonds depends on the conformation, as well as on the in-
herent disulfide oxidation-reduction potential of the pro-
tein (for example see 7). Intracellular disulfide bonding is
influenced by the cellular redox potential, that is the con-
sequence mainly of the ratio of reduced and oxidized glu-
tathione. The redox state of the cytoplasm does not gener-
ally favor disulfide bond formation. However, based on
the in vitro studies the putative disulfide bonding of pro-
teins under cytosolic (reducing) redox conditions can be
rationalized by assuming that the redox potential of the
membrane proteins themselves must be higher than the
cytosolic redox (for example see 6) and that, in addition,
the conformation/organization of the proteins in the vi-
rally modified IC membranes favors the intermolecular
disulfide bonding and folding. Consistent with the first
idea could be the fact that, as analyzed by Western blots,
the viral membrane proteins are highly resistant to reduc-
tion and that quantitative reduction requires the addition
of 5% b-ME as well as high amounts of DTT (see also 49).
This observation may also explain why cytosolic disulfide
bonds of vv membrane proteins would naturally resist the
(physiological) reducing environment of the cytosol.
Collectively, our data argue the vv disulfide bonds play a
key role in the vaccinia viral life cycle. Apparently normal
looking IMV particles that lack detectable disulfide bonds
were seen in cells infected in the presence of DTT. These
data imply that assembly per se is not dependent on disul-
fide bonding and must therefore rely on other types of
protein interactions. However, the virions made in the
presence of DTT were not completely assembled since
they tended to loose their membranes in vivo and (more
clearly) upon their isolation. Together with our recent
data showing that treatment of purified virions with DTT
opens up the viral membranes (which we argue are not
fused into a continuous bilayer around the virus; see Fig.
1), these results clearly establish an important role of di-
sulfide bonds in vv membrane proteins. Both the in vitro
as well as the in vivo data show that in their absence the vi-
ral membranes are unable to remain tight around the par-
ticle and instead open up and detach from the underlying
core. At present the reason why the three membrane pro-
teins form homodimers as well as monomers is not clear.
This phenomenon is obviously needed for the stability of
the particle.
The role of the disulfide bonds of the vv core proteins is
less clear at present. An obvious idea that comes to mind
is that disulfide bonding during assembly will generate a
stable core, while reduction during entry makes it unstable
and primes it for disassembly. However, some results are
difficult to reconcile with this idea. For instance, in DTT
treated cells the cores are reduced but do not seem to fall
apart. Also, cores resist prolonged treatment of IMVs with
DTT in vitro (unpublished observations) and DTT-treated
IMVs retain full infectivity. And finally, it is known that
when uncoating of the cores after entry in prevented, theThe Journal of Cell Biology, Volume 144, 1999 278
cores may persist for hours in the cytoplasm (for example
see 27). When the IMV infects cells a viral core particle
indistinguishable from those produced by treating IMVs
with NP-40 and DTT (23) appears in the cytoplasm.
Within minutes this core starts to make a defined set of so-
called early mRNAs, a process that has been extensively
studied in vitro using NP-40/DTT-treated virions. From
such studies it is clear that, in vitro, this process of early
transcription requires a reducing environment (42). Al-
though it is very likely that the process of transcription it-
self requires reducing conditions, we would like to propose
that the reduction of the core may play a role as well. Such
a role can for example consist of a conformational change
of the core structure that is required to activate the tran-
scription machinery (that is contained in the core; 40).
Alternatively, such a structural change could (also) be
needed to allow the newly synthesized mRNA to exit the
core, a process that has been shown to occur in vitro (29).
Since the questions of changes that accompany transcrip-
tion in vitro or the overall process in vivo have never been
seriously addressed, a testing of our proposed scenario
would require further advances in our understanding if
these aspects of vaccinia virus life cycle.
In summary, disulfide bonds are an established mecha-
nism for stabilizing proteins in extra-cytoplasmic locations.
Our data show that vv has evolved the novel ability to use
two different kinds of unusual disulfide bonds in its life cy-
cle. The first are represented in a number of viral core pro-
teins: these appear to be assembled only after the intracel-
lular virions have sealed themselves from the cytoplasm, in
effect forming an extra-cytoplasmic compartment that fa-
vors disulfide bonding. The second bonds are seen in three
vv membrane proteins that seem to have evolved the ca-
pacity to fold their (cytoplasmic domains) into a confor-
mation that allows intermolecular disulfide bonds to as-
semble that can resist the reducing environment of the
cytoplasm.
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